Author:
Neumann Natalie R.,Hoyte Christopher O.
Publisher
Springer International Publishing
Reference134 articles.
1. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–8. https://doi.org/10.1038/nrc1074.
2. Rutman RJ, Cantarow A, Paschkis KE. Studies in 2-acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma. Cancer Res. 1954;14(2):119–23.
3. Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 1989;16(4):215–37.
4. Daher GC, Harris BE, Diasio RB. Metabolism of pyrimidine analogues and their nucleosides. Pharmacol Ther. 1990;48(2):189–222.
5. National Cancer Institute Publications. NCI dictionaries. NCI dictionary of cancer terms. Bethesda: National Cancer Institute; 2020. https://www.cancer.gov/publications/dictionaries/cancer-terms.